List of HTA agencies and processes in different countries
Join our community on Telegram!
Join the biggest community of Pharma students and professionals.
HTA (Health Technology Assessment) agencies and processes can vary significantly from one country to another. Here is a list of some prominent HTA agencies in different countries and a brief description of their processes:
1. National Institute for Health and Care Excellence (NICE) - United Kingdom:
NICE is responsible for providing evidence-based guidance on the use of health technologies, including pharmaceuticals and medical devices, within the National Health Service (NHS). They conduct systematic reviews and economic evaluations to assess the cost-effectiveness of healthcare interventions.
2. Pharmaceutical Benefits Advisory Committee (PBAC) - Australia:
The PBAC assesses new pharmaceutical products to determine their cost-effectiveness and potential inclusion in the Pharmaceutical Benefits Scheme (PBS). The PBS provides subsidized medicines to Australian residents.
3. Haute Autorité de Santé (HAS) - France:
HAS evaluates the medical benefit of drugs, medical devices, and procedures, taking into account their clinical efficacy, safety, and cost-effectiveness. It provides recommendations to the French government and plays a key role in determining reimbursement.
4. Canadian Agency for Drugs and Technologies in Health (CADTH) - Canada:
CADTH is responsible for conducting health technology assessments to support the decision-making process of public healthcare payers in Canada. They provide recommendations on drug reimbursement and the use of medical technologies.
5. Institute for Quality and Efficiency in Health Care (IQWiG) - Germany:
IQWiG is an independent agency that evaluates the benefit and harms of medical interventions, including drugs and medical devices, based on clinical evidence. Their assessments inform reimbursement decisions and healthcare policies in Germany.
6. Agency for Health Technology Assessment and Tariff System (AOTMiT) - Poland:
AOTMiT evaluates healthcare technologies, including pharmaceuticals and medical devices, to determine their cost-effectiveness and make recommendations for reimbursement in Poland.
7. Health Technology Assessment Institute (IETS) - Sweden:
IETS is responsible for assessing the effectiveness, safety, and cost-effectiveness of health technologies, playing a role in decision-making on reimbursement and access to medical interventions in Sweden.
8. Health and Medical Technology Assessment Committee (MTAC) - Thailand:
MTAC evaluates the clinical effectiveness and cost-effectiveness of medical technologies and provides recommendations to the Thai government for inclusion in the National List of Essential Medicines (NLEM) and the National Health Security Office (NHSO) benefit package.
9. Medical Services Advisory Committee (MSAC) - Australia:
MSAC evaluates the safety, clinical effectiveness, and cost-effectiveness of medical procedures and technologies, making recommendations for public funding under the Medicare Benefits Schedule in Australia.
Please note that HTA agencies may have undergone changes or evolved and there may be additional agencies established in different countries. Additionally, the processes and responsibilities of HTA agencies can differ, depending on the country's healthcare system and regulatory framework.
